About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
20 Oct,2020
TonBridge Medical held a launch meeting for the Clot Retriever Device and the Intracranial Support Catheters
In October 2020, TonBridge Medical held a launch meeting for the Clot Retriever Device and the Intracranial Support Catheters at the OCIN2020 Innovation Forum. At the meeting, Liu Jianmin and many oth...
more
28 Sep,2020
The Clot Retriever Device obtained medical device registration certificate
In September 2020, the Clot Retriever Device independently developed by Zhuhai TonBridge Medical Technology Co., Ltd. obtained the medical device registration certificate approved by NMPA.The Clot Ret...
more
22 Sep,2020
The Intracranial Support Catheter obtained medical device registration certificate
In September 2020, the Intracranial Support Catheter independently developed by Zhuhai TonBridge Medical Technology Co., Ltd. obtained the medical device registration certificate approved by NMPA.The ...
more
12 Oct,2019
ThromBite™ gained CE certificate
In January 2020, ThromBite™ Clot Retriever Device, independently developed by Zhuhai TonBridge Medical Tech. Co., Ltd, gained CE certificate.ThromBite™ Clot Retriever Device is designed for the trea...
more
12 Oct,2019
Zylox-TonBridge Medical was selected as one of the top 50 most valuable investment companies in China in 2019
Recently, the Billboard of the "Top 50 Most Valuable Investment Companies in China" in 2019 have been unveiled. As the first domestic company with an investment dimension, Venture50 has acco...
more
12 Oct,2019
TonBridge Medical won the runner-up of the 2018 China Innovation and Entrepreneurship Competition in Biomedical Industry Finals (medical device group champion)
Recently, the 7th China Innovation and Entrepreneurship Contest Biomedical Industry Finals, guided by the Ministry of Science and Technology, the Ministry of Finance, the Ministry of Education, the Ce...
more
